HER2-positive feline mammary carcinoma

HER2-positive feline mammary carcinoma

Bibliographic Details
Main Authors:	Marques, Cláudia, Correia, Jorge, Ferreira, Fernando
Format:	Online
Language:	English
Published:	Impact Journals LLC 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032681/

Similar Items

CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors
by: Cláudia S. Marques, et al.
Published: (2018-07-01)

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status
by: Soares, Maria, et al.
Published: (2016)

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
by: Ordás, Javier, et al.
Published: (2007)

Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
by: Figueira, Ana Catarina, et al.
Published: (2014)

Serum Amyloid A Promotes Invasion of Feline Mammary Carcinoma Cells
by: TAMAMOTO, Takashi, et al.
Published: (2014)

Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma
by: MICHISHITA, Masaki, et al.
Published: (2015)

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
by: Caliari, Diego, et al.
Published: (2014)

Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions.
by: Prospero Civita, et al.

P-cadherin expression in feline mammary tissues
by: Figueira, A Catarina, et al.
Published: (2010)

Lymphatic vessels assessment in feline mammary tumours
by: Sarli, Giuseppe, et al.
Published: (2007)

P-Cadherin Expression in Feline Mammary Tissues
by: Figueira, Ana Catarina, et al.
Published: (2012)

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
by: De Giovanni, Carla, et al.
Published: (2014)

Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ
by: Estévez, Laura G, et al.
Published: (2014)

Four cases of cell cannibalism in highly malignant feline and canine tumors
by: Ferreira, Fernando Costa, et al.
Published: (2015)

Feline mammary tumours in western Canada. A retrospective study
by: Abdul Rahman, Sheikh Omar
Published: (1980)

CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
by: Ferrari, Angelo, et al.
Published: (2012)

First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases
by: Pérez-Alenza, M Dolores, et al.
Published: (2004)

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
by: Maniscalco, Lorella, et al.
Published: (2013)

Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway
by: Pang, L.Y., et al.
Published: (2013)

Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
by: Adelfinger, Marion, et al.
Published: (2014)

CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice
by: Chen, Xuguang, et al.
Published: (2016)

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
by: Bandini, Silvio, et al.
Published: (2013)

HER2-positive gastric cancer
by: Boku, Narikazu
Published: (2013)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
by: Schwall, RH, et al.
Published: (2003)

Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
by: Fry, Elizabeth A., et al.
Published: (2013)

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
by: Eralp, Yesim, et al.
Published: (2004)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
by: Ishimine, Yu, et al.
Published: (2015)

Isolation and identification of feline calicivirus and feline herpesvirus in Southern Brazil
by: Henzel, Andréia, et al.
Published: (2012)

Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression
by: Zhang, Yi, et al.
Published: (2011)

A Case Report of Feline Pituitary Carcinoma with Hypercortisolism
by: KIMITSUKI, Kazunori, et al.
Published: (2013)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
by: Lipton, Allan, et al.
Published: (2013)

Expression profiles of immune mediators in feline Coronavirus-infected cells and clinical samples of feline Coronavirus-positive cats
by: Nikoo Safi, et al.
Published: (2017-04-01)

HER-3 expression in HER-2-amplified breast carcinoma
by: Czopek, Jacek, et al.
Published: (2013)

Mammary Carcinoma
by: Ray, P. N.
Published: (1950)

Targeted therapy for HER2 positive breast cancer
by: Incorvati, Jason A, et al.
Published: (2013)

Interlaboratory concordance in HER-2 positive breast cancer
by: Nives Jonjić, et al.
Published: (2015-01-01)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Feline consumption
by: Morris, “The Cat” Holbrook
Published: (1997)

HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast
by: Kito, Katsumi, et al.
Published: (2014)

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
by: Mendes, Diogo, et al.
Published: (2015)